SCHEMBL12181749

SCHEMBL12181749

Cn1nc(C(F)(F)F)cc1-c1ccc(N)cc1[N+](=O)[O-]

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.43
TSHR P16473 3/20 0.43
CYP3A4 P08684 2/20 0.43
RECQL P46063 1/20 0.43
RAB9A P51151 3/20 0.43
NPC1 O15118 2/20 0.43
ALOX15 P16050 2/20 0.42
TDP1 Q9NUW8 2/20 0.42
PTGS2 P35354 5/20 0.40
PTGS1 P23219 4/20 0.40
ALOX5 P09917 1/20 0.40
MAPK1 P28482 1/20 0.40
HSD17B10 Q99714 1/20 0.40
L3MBTL1 Q9Y468 1/20 0.40
HDAC3 O15379 1/20 0.39
HDAC4 P56524 1/20 0.39
HDAC1 Q13547 1/20 0.39
HDAC7 Q8WUI4 1/20 0.39
HDAC2 Q92769 1/20 0.39
HDAC10 Q969S8 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15165015 0.83 ALDH1A1 (0.50) ALDH1A1TSHRCYP3A4RECQLRAB9A
SCHEMBL12181698 0.81 RAB9A (0.45) ALDH1A1TSHRRAB9ANPC1PTGS2
SCHEMBL14879552 0.80 RAB9A (0.44) ALDH1A1TSHRRAB9ANPC1PTGS2
SCHEMBL19551683 0.77 NPC1 (0.54) TSHRCYP3A4RAB9ANPC1ALOX15
SCHEMBL29718696 0.77 NPC1 (0.54) TSHRCYP3A4RAB9ANPC1ALOX15
SCHEMBL5578078 0.74 PTGS2 (0.46) ALDH1A1RAB9ANPC1PTGS2PTGS1
SCHEMBL2592032 0.73 ORAI1 (0.55) ALDH1A1RAB9ANPC1TDP1MAPK1
SCHEMBL15164957 0.73 CRACR2A (0.48) ALDH1A1RAB9AHDAC3HDAC4HDAC1
SCHEMBL20916591 0.73 PTGS2 (0.52) TSHRCYP3A4RAB9ANPC1ALOX15
SCHEMBL29718839 0.73 PTGS2 (0.52) TSHRCYP3A4RAB9ANPC1ALOX15

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9353099-B2 Compounds that modulate intracellular calcium CALCIMEDICA, INC. (US) 2016-05-31 US disclosed
US-20150361075-A1 COMPOUNDS THAT MODULATE INTRACELLULAR CALCIUM AVENUE CAPITAL MANAGEMENT II, L.P. 2015-12-17 US disclosed
US-9090612-B2 Compounds that modulate intracellular calcium CALCIMEDICA, INC. (US) 2015-07-28 US disclosed
US-20140243366-A1 COMPOUNDS THAT MODULATE INTRACELLULAR CALCIUM CALCIMEDICA, INC. (US) 2014-08-28 US disclosed
US-8754219-B2 Compounds that modulate intracellular calcium CALCIMEDICA, INC. (US) 2014-06-17 US disclosed
US-20130203818-A1 COMPOUNDS THAT MODULATE INTRACELLULAR CALCIUM CALCIMEDICA, INC. (US) 2013-08-08 US disclosed
WO-2011139765-A2 COMPOUNDS THAT MODULATE INTRACELLULAR CALCIUM CALCIMEDICA, INC. (US) 2011-11-10 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140243366-A1 COMPOUNDS THAT MODULATE INTRACELLULAR CALCIUM ORAI1, SARAF, RYR2 ALDH1A1 4409/4885TSHR 4111/4885CYP3A4 4329/4885
US-20130203818-A1 COMPOUNDS THAT MODULATE INTRACELLULAR CALCIUM ORAI1, SARAF, RYR2 ALDH1A1 4409/4885TSHR 4111/4885CYP3A4 4329/4885
US-20150361075-A1 COMPOUNDS THAT MODULATE INTRACELLULAR CALCIUM ORAI1, SARAF, RYR2 ALDH1A1 4409/4885TSHR 4111/4885CYP3A4 4329/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.